Patient#	Sample#	I kappa B alpha/PIK3R1:(NF kappa B1 p50/RelA/I kappa B alpha, active),(PI3K, active),	NF kappa B1 p50/c-Rel:(NF kappa B1 p105/c-Rel, active),	BCL3:(BCL3, protein),	IKBKB:(IKBKB, protein),	LCK:(LCK, protein),	MAPK14:(MAPK14, protein),	PIK3CA:(NF kappa B1 p50/RelA/I kappa B alpha, active),(PI3K, active),(PIK3CA, protein),	RELA:(RELA, protein),	SRC:(SRC, protein),	SYK:(SYK, protein),	ARRB2:(ARRB2, protein),(CK2, active),(MAPK14, active),(response to UV, active),	BCL3/RelA:(BCL3, active),(RELA, active),	NFKB1:(IKBKB, active),(NFKB1, protein),	NFKBIA:(LCK, active),(NF kappa B1 p50/RelA/I kappa B alpha, active),(NFKBIA, protein),(SRC, active),(SYK, active),(response to oxidative stress, active),	NF kappa B1 p105/RelA:(NFKB1, active),(RELA, active),	NF kappa B1 p50/RelA/I kappa B alpha/beta Arrestin2:(ARRB2, active),(NF kappa B1 p50/RelA/I kappa B alpha, active),	NF kappa B1 p105/p50:(NFKB1, active),(beta TrCP1/SCF ubiquitin ligase complex, active),	NF kappa B1 p50/RelA:(CK2, active),(MAPK14, active),(NF kappa B1 p105/RelA, active),(NF kappa B1 p50/RelA/I kappa B alpha, active),(PI3K, active),(response to UV, active),	cell death:(NF kappa B1 p50/RelA/I kappa B alpha/beta Arrestin2, active),	NF kappa B1 p50 dimer:(IKBKB, active),(NF kappa B1 p105/p50, active),	degradation:(NF kappa B1 p105/p50, active),(NFKBIA, active),	positive regulation of anti-apoptosis:(NF kappa B1 p50/RelA, active),	BCL3/NF kappa B1 p50:(BCL3, active),(NF kappa B1 p50 dimer, active),	
